Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 18, 2026 00:18 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 30,000 | $2.98 | $89,529.00 |
DisclosureSEC source: 0001193125-26-354496 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 936,657 F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.92 to $3.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 21:03 UTC |
Jayaraman Vivek KChief Executive Officer
|
SaleCommon Stock | 16,666 | $3.16 | $52,664.56 |
DisclosureSEC source: 0001193125-26-309044 · ownership.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,232,211 F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 23:18 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantPerformance Rights · Derivative | 369,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001605456-26-000008 · ownership.xml · derivative · entry 4 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 369,686 Underlying: Common Stock · 369,686 shares Expires 2029-07-01 F4 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of Cerus common stock. The performance rights vest upon Cerus common stock achieving a specified price per share. F4 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of Cerus common stock. The performance rights vest upon Cerus common stock achieving a specified price per share. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 23:18 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantCommon Stock | 554,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001605456-26-000008 · ownership.xml · nonDerivative · entry 3 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,248,877 F3 · shares: Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 33% of the grant vesting on July 1, 2027, and 67% of the grant vesting on July 1, 2028, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:19 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 33,676 | $2.94 | $99,105.10 |
DisclosureSEC source: 0001459351-26-000011 · ownership.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,062,188 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.84 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:19 UTC |
Green Kevin DennisChief Financial Officer
|
GrantCommon Stock | 63,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001459351-26-000011 · ownership.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,095,864 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:18 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 42,359 | $2.94 | $124,658.30 |
DisclosureSEC source: 0001605456-26-000008 · ownership.xml · nonDerivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,694,348 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.84 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:18 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001605456-26-000008 · ownership.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,736,707 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:13 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 101,919 | $2.94 | $299,937.43 |
DisclosureSEC source: 0001377258-26-000008 · ownership.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,053,036 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.84 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:13 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantCommon Stock | 192,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001377258-26-000008 · ownership.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,154,955 Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:15 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 24,329 | $2.94 | $71,597.81 |
DisclosureSEC source: 0001564252-26-000010 · ownership.xml · nonDerivative · entry 2 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 966,657 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.84 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 23:15 UTC |
Jensen ChrystalChief Legal Officer
|
GrantCommon Stock | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001564252-26-000010 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 990,986 Read SEC document |
| June 09, 2026 Filed Jun 12, 2026 01:17 UTC |
BJERKHOLT ERICDirector
|
SaleCommon Stock | 20,454 | $2.60 | $53,180.40 |
DisclosureSEC source: 0001193125-26-268227 · ownership.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,679 Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 23:59 UTC |
Lucena AnnDirector
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-254120 · ownership.xml · nonDerivative · entry 1 Lucena Ann · CIK 0001876751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,284 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 23:54 UTC |
BJERKHOLT ERICDirector
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-254116 · ownership.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,133 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 23:50 UTC |
NACHTSHEIM JAMI KDirector
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-254113 · ownership.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,362 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 23:37 UTC |
Witney FrankDirector
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-254094 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,059 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 23:35 UTC |
Gregory Dean A.Director
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-254090 · ownership.xml · nonDerivative · entry 1 Gregory Dean A. · CIK 0002028395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,725 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 23:33 UTC |
Shan HuaDirector
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-254086 · ownership.xml · nonDerivative · entry 1 Shan Hua · CIK 0001937467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,386 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 23:46 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 16,667 | $3.00 | $50,001.00 |
DisclosureSEC source: 0001193125-26-254106 · ownership.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,656,707 F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| May 01, 2026 Filed May 5, 2026 22:31 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 16,667 | $3.00 | $50,001.00 |
DisclosureSEC source: 0001193125-26-206993 · ownership.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,673,374 F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:51 UTC |
Green Kevin DennisChief Financial Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001459351-26-000009 · ownership.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,240,551 F1 · shares: Granted in the form of a RSUs representing a contingent right to receive one share of common stock of the Issuer. The RSUs vest in full one year from date of the grant, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 21:43 UTC |
Jensen ChrystalChief Legal Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001564252-26-000008 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,146,131 F1 · shares: Granted in the form of a RSUs representing a contingent right to receive one share of common stock of the Issuer. The RSUs vest in full one year from date of the grant, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 23:44 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 165,200 | $1.66 | $273,769.44 |
DisclosureSEC source: 0001605456-26-000006 · ownership.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,747,674 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.73 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 23:44 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 447,757 | $1.66 | $742,022.90 |
DisclosureSEC source: 0001377258-26-000006 · ownership.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,998,493 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.73 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 23:44 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 127,544 | $1.66 | $211,365.92 |
DisclosureSEC source: 0001459351-26-000007 · ownership.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,040,551 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.73 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 23:43 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 101,740 | $1.66 | $168,603.53 |
DisclosureSEC source: 0001296322-26-000009 · ownership.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 777,361 F1 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.73 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 01:35 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 40,426 | $1.88 | $76,029.18 |
DisclosureSEC source: 0001296322-26-000004 · ownership.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 879,101 F3 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.855 to $1.91 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 11:05 UTC Amendment |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 40,426 | $1.88 | $76,029.18 |
DisclosureSEC source: 0001296322-26-000007 · ownership.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 879,101 F1 · shares: Represents shares sold pursuant to a 10b5-1 plan and does not represent a discretionary sale by the reporting person. F5 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.855 to $1.91 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 01:56 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 27,796 | $2.01 | $55,744.88 |
DisclosureSEC source: 0001459351-26-000005 · ownership.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,168,095 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: Represents a weighted average sales price. These shares were sold in multiple transactions in a block trade transaction. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price in the block trade. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 01:35 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 24,235 | $2.01 | $48,603.29 |
DisclosureSEC source: 0001296322-26-000004 · ownership.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 919,527 F1 · kind: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in a block trade per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold pursuant to such block trade. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 01:31 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 30,845 | $2.01 | $61,859.65 |
DisclosureSEC source: 0001564252-26-000004 · ownership.xml · nonDerivative · entry 2 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,059,139 F1 · kind: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in a block trade per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold pursuant to such block trade. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 01:30 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 34,094 | $2.01 | $68,375.52 |
DisclosureSEC source: 0001605456-26-000004 · ownership.xml · nonDerivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,912,874 F1 · kind: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in a block trade per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold pursuant to such block trade. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 78,187 | $2.01 | $156,804.03 |
DisclosureSEC source: 0001377258-26-000004 · ownership.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,446,250 F1 · kind: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in a block trade per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold pursuant to such block trade. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 11:05 UTC Amendment |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 24,235 | $2.01 | $48,603.29 |
DisclosureSEC source: 0001296322-26-000007 · ownership.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 919,527 F3 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: Represents a weighted average sales price. These shares were sold in a block trade per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold pursuant to such block trade. Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 01:56 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 55,225 | $2.06 | $113,901.56 |
DisclosureSEC source: 0001459351-26-000005 · ownership.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,195,891 F1 · shares: This transaction was executed pursuant to a 10b5-1 plan. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.015 to $2.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 01:56 UTC |
Green Kevin DennisChief Financial Officer
|
GrantCommon Stock | 63,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001459351-26-000005 · ownership.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,251,116 Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 01:35 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 61,233 | $2.06 | $126,305.31 |
DisclosureSEC source: 0001296322-26-000004 · ownership.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 943,762 F4 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 01:35 UTC |
Benjamin Richard JChief Medical Officer
|
GrantCommon Stock | 55,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001296322-26-000004 · ownership.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,004,995 Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 01:31 UTC |
Jensen ChrystalChief Legal Officer
|
GrantCommon Stock | 55,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001564252-26-000004 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,083,514 Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 01:30 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantCommon Stock | 80,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001605456-26-000004 · ownership.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,946,968 Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantCommon Stock | 193,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001377258-26-000004 · ownership.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,524,437 Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 11:05 UTC Amendment |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 61,233 | $2.06 | $126,299.19 |
DisclosureSEC source: 0001296322-26-000007 · ownership.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 943,762 F1 · shares: Represents shares sold pursuant to a 10b5-1 plan and does not represent a discretionary sale by the reporting person. F2 · price: Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 05, 2026 Filed Mar 10, 2026 11:05 UTC Amendment |
Benjamin Richard JChief Medical Officer
|
GrantCommon Stock | 55,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001296322-26-000007 · ownership.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,004,995 Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:37 UTC |
Benjamin Richard JChief Medical Officer
|
GrantCommon Stock | 264,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001296322-26-000002 · ownership.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 949,775 F1 · kind: Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2027, and 66% of the grant vesting on March 12, 2028, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:36 UTC |
Green Kevin DennisChief Financial Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001459351-26-000003 · ownership.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,187,262 F1 · kind: Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2027, and 66% of the grant vesting on March 12, 2028, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 5,837 and 5,558 shares purchased under Issuer's Employee Stock Purchase Plan on 08/29/25 and 02/27/26, respectively. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:33 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantCommon Stock | 1,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001377258-26-000002 · ownership.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,331,167 F1 · kind: Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2027, and 66% of the grant vesting on March 12, 2028, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 5,318 and 10,004 shares purchased under Issuer's Employee Stock Purchase Plan on 08/29/25 and 02/27/26, respectively. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:31 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantCommon Stock | 420,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001605456-26-000002 · ownership.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,866,648 F1 · kind: Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2027, and 66% of the grant vesting on March 12, 2028, subject to the Reporting Person's continuous service to the Issuer through such vesting date. F2 · balance_after: Includes 5,318 and 10,004 shares purchased under Issuer's Employee Stock Purchase Plan on 08/29/25 and 02/27/26, respectively. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:29 UTC |
Jensen ChrystalChief Legal Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001564252-26-000002 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,028,294 F1 · kind: Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2027, and 66% of the grant vesting on March 12, 2028, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 21:07 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 55,000 | $1.70 | $93,500.00 |
DisclosureSEC source: 0001193125-25-300504 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 728,294 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.